New genetic drug validation paper out in Science Translation Medicine



Our new paper describes a collaborative effort with the Broad Institute, the University of Vermont and others to develop novel treatments for cryptosporidiosis. In this study we provide the first rigorous genetic validation of a drug target in Cryptosporidium by using CRISPR/Cas9 directed engineering of drug resistance. Check it out at Science Translational Medicine





Featured Posts
Posts Are Coming Soon
Stay tuned...
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©  by Boris Striepen.

  • Twitter Social Icon